Tag Archives: Pfizer

Via email from hate group leader Monica Cole: Pfizer’s new commercial promotes the COVID-19 booster and flu shot, informing viewers that both shots can be taken together. The ad also includes a double entendre that is inappropriate and unnecessary. Foul language (or the implication of it) is not needed in this or any commercial. Yet, that is obviously what Pfizer …

The Texas Tribune reports: Texas Attorney General Ken Paxton accused drugmaker Pfizer of fear-mongering and lies about the effectiveness of its COVID-19 vaccine, which the company insinuated would end the pandemic, according to a lawsuit Paxton announced Thursday. “In a nutshell, Pfizer deceived the public,” reads the 54-page lawsuit, filed in a Lubbock state district court. The lawsuit alleges Pfizer …

CNN reports: Everyone ages 6 months and older should get an updated Covid-19 vaccine, the US Centers for Disease Control and Prevention said Tuesday, to help lower the risk of severe illness, hospitalization or death from the coronavirus. Dr. Mandy Cohen, director of the agency, signed off on recommendations from the Advisory Committee on Immunization Practices or ACIP, a panel …

Via press release from the FDA: Today, the U.S. Food and Drug Administration took action approving and authorizing for emergency use updated COVID-19 vaccines formulated to more closely target currently circulating variants and to provide better protection against serious consequences of COVID-19, including hospitalization and death. Today’s actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and …

CBS News reports: The Biden administration’s planned fall COVID-19 booster campaign cleared a key regulatory hurdle, after the Food and Drug Administration announced Wednesday it has authorized updated shots adapted for the Omicron variant of the virus for Americans as young as 12 years old. People could get the new booster as little as 2 months after their last shot …

Bloomberg Law reports: Moderna Inc. said it’s suing Pfizer Inc. and BioNTech SE, claiming the technology in the partners’ Covid-19 shot infringes on its patents, a move that sets the stage for a massive legal clash between the three vaccine titans. Moderna, in a statement Friday, accused Pfizer and BioNTech of violating intellectual property protecting key elements of Moderna’s messenger …

The Associated Press reports: Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives — a key step toward opening a fall booster campaign. The Food and Drug Administration ordered vaccine makers to tweak their shots to target BA.4 and BA.5 that are better than ever at dodging immunity from earlier …

NBC News reports: The Food and Drug Administration on Friday authorized both Pfizer-BioNTech and Moderna’s Covid-19 vaccines for young children, though the CDC still needs to sign off before shots can be administered. The Pfizer vaccine was authorized for children ages 6 months to 4 years, while the Moderna vaccine was authorized for children ages 6 months to 5 years, …

USA Today reports: People age 50 and up are now eligible for a second booster dose of COVID-19 vaccine at least four months after their first, the Food and Drug Administration said Tuesday. “Based on an analysis of emerging data, a second booster dose of either the Pfizer-BioNTech or Moderna COVID-19 vaccine could help increase protection levels for these higher-risk …

The Washington Post reports: Pharmaceutical giant Pfizer and its partner, BioNTech, will seek emergency authorization for a second booster shot of their coronavirus vaccine for people 65 and older, an effort to bolster waning immunity that occurs several months after the first booster. The submission to the Food and Drug Administration, anticipated as soon as Tuesday, is expected to include …

CNBC reports: Pfizer plans to submit data to the Food and Drug Administration for a fourth Covid shot soon, and it’s working on a vaccine that protects against all coronavirus variants, CEO Albert Bourla told CNBC. “I think we’re going to submit to FDA a significant progress of data about the need for a fourth dose, and they need to …

NBC News reports: Pfizer-BioNTech is postponing its rolling application to the Food and Drug Administration to expand the use of its two-dose Covid-19 vaccine for children ages 6 months to 4 years. The move means that vaccines for this age group will not be available in the coming weeks, a setback for parents eager to vaccinate their young children. Pfizer …

The Washington Post reports: Coronavirus vaccines for children younger than 5 could be available far sooner than expected — perhaps by the end of February — under a plan that would lead to the potential authorization of a two-shot regimen in the coming weeks, people briefed on the situation said Monday. The FDA urged the companies to submit the application …

Reuters reports: Pfizer Inc and BioNTech SE said on Tuesday they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen. Banking on volunteers in the United States, the companies plan to test the immune response …

CBS News reports: President Biden announced on Tuesday that he’s directing his team to double the United States’ order of Pfizer antiviral pills from 10 million COVID-19 treatment courses to 20 million treatment courses, and the delivery will be accelerated from September to June. “We may need even more. That’s the estimate we need right now,” Mr. Biden said, noting …

CNBC reports: The Food and Drug Administration on Monday expanded eligibility for Pfizer and BioNTech booster shots to children ages 12 to 15 years old, as school restarts after winter break amid a surge of Covid infections across the U.S. The FDA also shortened the time between primary vaccination and the booster dose to at least five months, down from …

The Associated Press reports: U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus. The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited. All of the previously …

Bloomberg News reports: The U.S. Food and Drug Administration is poised to authorize a pair of pills from Pfizer Inc. and Merck & Co. to treat Covid-19 as soon as this week, according to people familiar with the matter — a milestone in the fight against the pandemic that will soon expand therapies for the ill. An announcement may come …

NBC News reports: Additional data from Pfizer’s clinical trial of its oral Covid-19 antiviral drug confirm the treatment’s high level of effectiveness, the company said in a news release Tuesday. In the final analysis of its Phase 2/3 clinical trial, the antiviral, called Paxlovid, was found to be 89 percent effective at preventing high-risk people from being hospitalized or dying …

The Associated Press reports: Vaccine makers are racing to update their COVID-19 shots against the newest coronavirus threat even before it’s clear a change is needed, just in case. Experts doubt today’s shots will become useless but say it’s critical to see how fast companies could produce a reformulated dose and prove it works — because whatever happens with omicron, …